JUN 15, 2020 3:17 PM PDT

FDA Approves HPV Vaccine to Prevent Throat Cancer

WRITTEN BY: Annie Lennon

For around a decade, research has suggested that Gardasil, an HPV vaccine, could prevent throat cancer, a condition that affects 13,500 Americans every year. Now, the Food and Drug Administration (FDA) has approved the latest version of the vaccine, Gardasil 9, for that purpose.

“To have this extended to head and neck cancer is really very helpful for helping to inform the public that this serious disease, which has significant morbidity and mortality associated with it, can be prevented with the vaccine,” says Stewart Lyman, a pharmaceutical consultant. 

The first version of the Gardasil vaccine was approved in 2006 for women and girls aged between 9 and 26 to prevent infection by the HPV virus that can result in precancerous cervical lesions. As the lesions are not common to throat cancer, researchers weren’t sure how to prove that it works there too. 

HPV was first connected to throat cancer back in 1999. During a surge in the disease, researchers noticed that many cases of throat cancer seemed to come from the HPV virus. They also noticed that these cases seemed to be easier to treat, and most common in middle-aged men who had contracted the virus decades earlier. 

Although there is still no data confirming that the HPV vaccine can prevent throat cancer, the FDA has given the vaccine an accelerated approval. That means that its final decision will rely on research currently underway by Merck. In February, the pharmaceutical company began a study of 6,000 men to see whether the vaccine reduces their likelihood of HPV infection in their throats. 

While generally opposed to such accelerated approvals, Otis Brawley, an epidemiology professor at Johns Hopkins University, said that he is comfortable with the decision. He says that existing data amassed over the last ten years shows that there are already enough grounds for the vaccine to treat the cancer. He added that giving the vaccine to men too may make it possible to eradicate the HPV virus, and thus the cancers it causes. 

 

Sources: StatNews, Business Wire, Wolters Kluwer

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 05, 2020
Drug Discovery & Development
New Drug May Reduce Inflammation from COVID-19
JUL 05, 2020
New Drug May Reduce Inflammation from COVID-19
Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation ...
JUL 17, 2020
Drug Discovery & Development
Could Low-Dose Radiation Therapy Treat COVID-19?
JUL 17, 2020
Could Low-Dose Radiation Therapy Treat COVID-19?
Research from a century ago points towards the potential of low-dose radiation therapy (LDRT) for treating pneumonia. Ev ...
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
JUL 28, 2020
Cardiology
Looking to Newborns for Help Healing Scars on the Heart
JUL 28, 2020
Looking to Newborns for Help Healing Scars on the Heart
Scars are a badge of honor to many, but they are really just a consequence of the body’s repair response. The body ...
AUG 05, 2020
Drug Discovery & Development
New Drug Prevents Inherited Alzheimer's in Mice
AUG 05, 2020
New Drug Prevents Inherited Alzheimer's in Mice
Researchers at the Salk Institute have developed a new drug candidate that has successfully prevented Alzheimer's-re ...
Loading Comments...